In August 2012, a class action was brought on behalf of New Yorkers claiming, among other things, that the makers of pill, TA-65, which is marketed as an anti-aging supplement, “have failed to reasonably warn consumers of the potential dangerous consequences associated with TA-65 telomerase activation and malignant tumor formation.”  (Egan, et al. v. Telomerase Activation Sciences, Inc. et al., Case No. 652533/2012, S.C.N.Y.)

 


The Latest

Filters

TINA.org Files FTC Complaint against Homeaglow

Press Release

TINA.org Files FTC Complaint against Homeaglow

MADISON, CONN. Sept. 9, 2025 – An investigation by consumer advocacy organization truthinadvertising.org (TINA.org) has found that Homeaglow is deceptively advertising $19 home cleanings in order to lure consumers into…


Show More